ABATE, DAVIDE ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.711
EU - Europa 536
AS - Asia 299
AF - Africa 3
SA - Sud America 2
OC - Oceania 1
Totale 3.552
Nazione #
US - Stati Uniti d'America 2.706
IT - Italia 187
DE - Germania 146
SG - Singapore 143
CN - Cina 127
FI - Finlandia 57
FR - Francia 34
RU - Federazione Russa 29
GB - Regno Unito 28
SE - Svezia 23
UA - Ucraina 18
VN - Vietnam 16
IN - India 11
NL - Olanda 5
IE - Irlanda 3
MX - Messico 3
BE - Belgio 2
CA - Canada 2
MA - Marocco 2
BO - Bolivia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
IR - Iran 1
MG - Madagascar 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
Totale 3.552
Città #
Fairfield 385
Ann Arbor 276
Woodbridge 274
Houston 265
Chandler 211
Ashburn 192
Cambridge 189
Wilmington 153
Seattle 136
Singapore 122
Jacksonville 72
Padova 63
Boardman 56
Princeton 49
Beijing 44
San Diego 41
Santa Clara 39
Aprilia 31
Helsinki 31
Medford 28
Des Moines 23
Guangzhou 23
New York 19
Dong Ket 16
Nanjing 15
Ahmedabad 8
London 8
Milan 6
Falls Church 5
Jiaxing 5
Bergamo 4
Florence 4
Hebei 4
Norwalk 4
Rome 4
Spinea 4
Washington 4
Amsterdam 3
Dublin 3
Kharkiv 3
Nanchang 3
Pietro 3
Redwood City 3
Shenyang 3
Arce 2
Azzano San Paolo 2
Brussels 2
Casablanca 2
Changsha 2
Columbus 2
Frankfurt am Main 2
Hanover 2
Jinan 2
Marano Di Napoli 2
North York 2
Nürnberg 2
Ogden 2
Paris 2
Pianiga 2
Rovigo 2
Trezzo sull'Adda 2
Verona 2
Vicenza 2
Zhengzhou 2
Acton 1
Adria 1
Ardabil 1
Auckland 1
Bari 1
Bonate Sopra 1
Casalecchio di Reno 1
Castelfranco Veneto 1
Chicago 1
Chiswick 1
Cochabamba 1
Costa Mesa 1
Coventry 1
Crotone 1
Dallas 1
Duncan 1
Düsseldorf 1
Falkenstein 1
Fossano 1
Fuzhou 1
Genova 1
Guidonia 1
Gunzenhausen 1
Hangzhou 1
Hefei 1
Kilburn 1
Las Vegas 1
Latina 1
Leawood 1
Los Angeles 1
Manila 1
Marigliano 1
Moscow 1
New Bedfont 1
Ningbo 1
Nuremberg 1
Totale 2.910
Nome #
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo' 165
Delayed acquisition of high avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients. 158
A Prospective Study on Modulation of Immunosuppression for Epstein-Barr Virus Reactivation in Pediatric Patients Who Underwent Unrelated Hematopoietic Stem-Cell Transplantation. 153
A Prospective Study on the Predictive Value of Plasma BK Virus-DNA Load for Hemorrhagic Cystitis in Pediatric Patients After Stem Cell Transplantation 147
Burkholderia cepacia complex isolation in non-polypoid chronic rhinosinusitis 138
Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection 138
Optimization of Interferon gamma ELISPOT assay to detect Human Cytomegalovirus specific T-cell responses in solid organ transplants 132
Cytomegalovirus (CMV) enzyme-linked immunosorbent spot assay but not cmv quantiferon assay is a novel biomarker to determine risk of congenital cmv infection in pregnant women 130
Avidity of immunoglobulin G directed against human Cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. 127
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients. 125
Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated with Increased Risk of Fetal Infection in Primarily Infected Pregnant Women 123
Cytomegalovirus infection in pregnancy: a still complicated diagnostic problem 122
High Cytomegalovirus (CMV) DNAemia predicts CMV sequelae in asymptomatic congenitally infected newborns born to women with primary infection during pregnancy. 118
Comparison of the cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV QuantiFERON cell-mediated immune assays in CMV-seropositive and -seronegative pregnant and nonpregnant women 117
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients. 113
Testing for cytomegalovirus in pregnancy 110
Diagnostic Utility of Human Cytomegalovirus-Specific T-Cell Response Monitoring in Predicting Viremia in Pediatric Allogeneic Stem-Cell Transplant Patients 107
Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. 102
P761 * Antibody mediated rejection related with CMV and EBV infection in heart transplants recipients: a possible relation with infection and complement activation. 101
The third international consensus guidelines on the management of cytomegalovirus in solid organ transplantation 92
Effects of TNF-alpha inhibitors on circulating Th17 cells in patients affected by severe psoriasis. 91
Effects of TNF-Alpha Inhibitors on Circulating Th17 Cells in Patients Affected by Severe Psoriasis 87
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. 86
CMV SPECIFIC IMMUNE RECONSTITUTION IN HTx PATIENTS TREATED WITH PRE-EMPTIVE STRATEGY: LIGHTS AND SHADOWS 83
EVALUATION OF HUMAN CYTOMEGALOVIRUS (CMV) SPECIFIC T-CELL RESPONSES PREDICTS EARLY AND LATE ONSET CMV INFECTION IN A COHORT OF KIDNEY TRANSPLANT RECIPIENTS 70
Interaction of CMV Prophylaxis and Pre-Emptive Strategies with Immunosuppressive Therapy: Potential Antiviral Effect of Everolimus 69
EVALUATION OF CMV SPECIFIC T-CELL RESPONSE IN HEART TRANSPLANT RECIPIENTS 67
null 65
Human cytomegalovirus DNAemia and preemptive treatment of CMV infection in children after hematopoietic stem-cell transplantation: Is any question settled? 62
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents IRF-3 activation in the interferon response. 60
Multicenter quality control study for human cytomegalovirus DNAemia quantification 58
Author Correction: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ (Nature, (2020), 584, 7821, (425-429), 10.1038/s41586-020-2488-1) 58
Risk of varicella-zoster virus (VZV) infection in patients treated with TNFα blockers: Rationale for evaluation of the impact of anti-TNFα treatment on VZV-specific T-cell immunity in psoriasis patients 52
The First 90 Days: Temporary Effect of Alemtuzumab on CMV Immune Reconstitution 51
Monitoraggio di pazienti in trattamento per Citomegalovirosi AIDS-correlata mediante il test dell'antigenemia pp65 34
Multicenter quality control study for humancytomegalovirus DNAemia quantification 32
Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. 24
Four-Year Follow-Up of the Maternal Immunological, Virological and Clinical Settings of a 36-Year-Old Woman Experiencing Primary Cytomegalovirus Infection Leading to Intrauterine Infection 16
Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients 13
Totale 3.596
Categoria #
all - tutte 13.107
article - articoli 13.107
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020464 0 0 0 0 65 57 55 74 75 67 49 22
2020/2021620 82 61 40 39 40 33 12 52 124 23 65 49
2021/2022539 14 72 59 27 36 19 33 57 30 7 61 124
2022/2023454 75 43 19 44 85 53 0 30 67 15 20 3
2023/2024220 3 34 29 14 15 33 13 23 6 7 17 26
2024/2025309 3 139 51 26 90 0 0 0 0 0 0 0
Totale 3.596